- Home
- MSEX vs MDXG Comparison
MSEX vs MDXG Comparison
Compare MSEX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSEX
- MDXG
- Stock Information
- Founded
- MSEX 1897
- MDXG 2006
- Country
- MSEX United States
- MDXG United States
- Employees
- MSEX N/A
- MDXG N/A
- Industry
- MSEX Water Supply
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- MSEX Utilities
- MDXG Health Care
- Exchange
- MSEX Nasdaq
- MDXG Nasdaq
- Market Cap
- MSEX 1.1B
- MDXG 1.1B
- IPO Year
- MSEX N/A
- MDXG N/A
- Fundamental
- Price
- MSEX $53.50
- MDXG $9.13
- Analyst Decision
- MSEX Sell
- MDXG Strong Buy
- Analyst Count
- MSEX 2
- MDXG 5
- Target Price
- MSEX $58.50
- MDXG $12.00
- AVG Volume (30 Days)
- MSEX 127.6K
- MDXG 760.4K
- Earning Date
- MSEX 10-31-2024
- MDXG 10-30-2024
- Dividend Yield
- MSEX 2.56%
- MDXG N/A
- EPS Growth
- MSEX 24.58
- MDXG N/A
- EPS
- MSEX 2.30
- MDXG 0.52
- Revenue
- MSEX $183,372,000.00
- MDXG $342,804,000.00
- Revenue This Year
- MSEX $14.26
- MDXG $9.56
- Revenue Next Year
- MSEX $6.01
- MDXG $9.19
- P/E Ratio
- MSEX $23.13
- MDXG $17.61
- Revenue Growth
- MSEX 10.14
- MDXG 10.93
- 52 Week Low
- MSEX $45.42
- MDXG $5.47
- 52 Week High
- MSEX $70.73
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- MSEX 19.33
- MDXG 53.33
- Support Level
- MSEX $58.19
- MDXG $8.93
- Resistance Level
- MSEX $60.28
- MDXG $9.60
- Average True Range (ATR)
- MSEX 1.76
- MDXG 0.32
- MACD
- MSEX -0.70
- MDXG -0.14
- Stochastic Oscillator
- MSEX 13.16
- MDXG 16.53
About MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm primarily operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.